Skip to main content
. 2025 Jan 11;11(1):3. doi: 10.1038/s41537-024-00552-3

Table 1.

Demographics and clinical measures.

Statistics
Characteristics Patients (N = 105) Healthy controls (N = 123) t/χ2 p
Sex (male/female) 63/42 71/52 χ2(1) = 0.121 0.728
Age (years) 23.11 (5.56) 23.57 (4.92) t(226) = 0.655 0.511
Educationa 12.97 (2.34) 15.52 (2.29) t(172) = 7.231 <0.001
Race/Ethnicityb – – χ2 (4) = 36.01 <0.001
Black 60 26 – –
Asian 3 22 – –
White 38 65 – –
Hispanic/Latino 2 6 – –
Other 2 2 – –
Parental occupationc 5.51 (4.88) 4.58 (4.03) χ2(1) = 21.121 0.174
Diagnosis, % – – – –
Schizophrenia 45.7 – – –
Bipolar disorder with psychosis 3.8 – – –
Schizophreniform disorder 6.7 – – –
Psychosis NOS 19 – – –
Brief psychotic disorder 3.8 – – –
MDD with psychosis 1.9 – – –
Schizoaffective disorder 19 – – –
Smoking, PPDd 0.21 (0.36) 0.01 (0.06) t(108.146) = −5.677 <0.001
Cannabis Use, % 55.2 1.62 t(115.488) = −10.704 <0.001
Duration of untreated psychosis 21.39 (36.11) – – –
BPRS total symptoms 47.46 (11.60) – – –
BPRS positive symptoms 10.37 (3.32) – – –
BPRS negative symptoms 5.42 (3.03) – – –

Values are Mean(SD), unless indicated otherwise.

BPRS Brief Psychiatric Rating Scale, MDD with psychosis, major depressive disorder with psychosis, NOS not otherwise specified, PPD packs per day.

aData missing for 27 patients and 27 healthy controls.

bPost hoc examination of adjusted residuals indicated more Black individuals in the FEP group, more Asian and White individuals in the HC group, and no significant between-group differences for the Latino/Hispanic or Other categories.

cRanks determined from Diagnostic interview for Genetic Studies (1–18 scale); Lower numerical value (higher rank) corresponds to higher socioeconomic status; Data missing for 5 patients and 3 healthy controls.

dData missing for 1 patient and 2 healthy controls.